東北大学 · 農学・生物学
Ueda教授の研究室では、再生医療を柱に、骨再生に寄与する間葉系stromal細胞（MSCs）の機能とその賦活化メカニズムを解明しています。特に、β-トロイダイトカルシウムホスファート（β-TCP）を含む新規バイオマテリアルを用いた幹細胞の骨形成能の評価を進め、臨床応用に向けたインプラント設計の最適化をめざしています。
Figures are computed from collected data and may differ slightly.
Bone marrow has been shown to contain a population of rare cells capable of differentiating to the cells that form various tissues. These cells, referred to as mesenchymal stem cells (MSCs), are capable of forming bone when implanted ectopically in an appropriate scaffold. The aim of this study was to investigate the potential of a new beta-tricalcium phosphate (beta-TCP) as a scaffold and to compare the osteogenic potential between beta-TCP and hydroxyapatite (HA). The beta-TCP and HA loaded wi
Open papers in the app to read, cite, and organize with AI.
